Table 2 The 3-and 5-year overall survival and cancer-specific survival in terms of patient characteristics
Variables | Overall Survival | Cancer-Specific Survival | ||
|---|---|---|---|---|
3-year (%) | 5-year (%) | 3-year (%) | 5-year (%) | |
Age, years | ||||
< 50 | 73.4 | 66.3 | 74.4 | 67.8 |
50–60 | 82.0 | 73.7 | 82.9 | 75.3 |
> 60 | 76.4 | 70.2 | 78.6 | 73.4 |
Tumor size, cm | ||||
≤ 12 | 77.4 | 72.8 | 79.0 | 75.0 |
> 12 | 78.4 | 68.4 | 79.6 | 70.4 |
Race | ||||
White | 79.2 | 72.5 | 80.7 | 74.8 |
Black | 57.7 | 40.3 | 61.3 | 42.8 |
Other | 76.8 | 68.8 | 77.4 | 70.0 |
Laterality | ||||
Unilateral | 81.8 | 75.1 | 83.1 | 77.2 |
Bilateral | 46.4 | 35.5 | 48.4 | 37.1 |
AJCC Stage (7th) | ||||
I | 91.2 | 85.6 | 92.2 | 87.2 |
II | 76.9 | 74.5 | 78.3 | – |
III | 46.7 | 34.1 | 49.0 | 35.8 |
IV | 40.8 | 27.9 | 41.7 | 30.5 |
Grade | ||||
I/II | 85.4 | 73.6 | 86.3 | 79.2 |
III | 75.9 | 67.4 | 77.0 | 69.2 |
IV | 78.5 | 75.0 | 80.9 | 77.3 |
Unknown | – | – | – | – |
LN dissected, n | ||||
No | 64.1 | 59.7 | 66.7 | 63.3 |
1–10 | 78.4 | 70.6 | 79.6 | 72.7 |
> 10 | 83.1 | 75.1 | 84.2 | 76.6 |
LN | ||||
No dissection or Negative | 78.5 | 70.7 | 79.9 | 72.6 |
Positive | 72.5 | 69.8 | 74.3 | 70.1 |
Organ Metastasis | ||||
No | 79.0 | 71.8 | 80.5 | 73.9 |
Yes | 30.5 | 22.2 | 30.5 | 26.7 |
Radiotherapy | ||||
No/Unknown | 78.0 | 70.7 | 79.5 | 72.9 |
Yes | 66.4 | 33.2 | 66.4 | – |
Chemotherapy | ||||
No/Unknown | 80.5 | 76.1 | 83.4 | 80.5 |
Yes | 77.2 | 69.4 | 78.4 | 71.1 |